Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26618538)

Published in PLoS One on November 30, 2015

Authors

Akio Nakashima1,2, Ichiro Ohkido1, Keitaro Yokoyama1, Aki Mafune1,2, Mitsuyoshi Urashima2, Takashi Yokoo1

Author Affiliations

1: Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
2: Division of Molecular Epidemiology, Jikei University School of Medicine, Tokyo, Japan.

Articles cited by this

Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA (2006) 9.53

Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr (2006) 4.74

Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int (2013) 4.37

Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet (2002) 3.90

Protective role of interleukin-10 in atherosclerosis. Circ Res (1999) 3.28

Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin Invest (2008) 2.24

Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care (2004) 2.24

Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med (2006) 2.22

Proton-pump inhibitor use is associated with low serum magnesium concentrations. Kidney Int (2013) 2.17

Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study. Hypertension (2013) 2.03

Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2007) 2.01

Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis. Am J Gastroenterol (2007) 1.62

Magnesium intake, bone mineral density, and fractures: results from the Women's Health Initiative Observational Study. Am J Clin Nutr (2014) 1.60

The importance of residual renal function in dialysis patients. Kidney Int (2006) 1.59

Cellular magnesium homeostasis. Arch Biochem Biophys (2011) 1.46

Omeprazole and refractory hypomagnesaemia. BMJ (2008) 1.43

Severe hypomagnesaemia in long-term users of proton-pump inhibitors. Clin Endocrinol (Oxf) (2008) 1.42

Hypomagnesemia. J Am Soc Nephrol (1999) 1.38

Proton pump inhibitors and severe hypomagnesaemia. Curr Opin Gastroenterol (2011) 1.36

Recent developments in intestinal magnesium absorption. Curr Opin Gastroenterol (2008) 1.30

Systematic review: hypomagnesaemia induced by proton pump inhibition. Aliment Pharmacol Ther (2012) 1.27

Hypomagnesemia induced by several proton-pump inhibitors. Ann Intern Med (2009) 1.26

Vitamin K-dependent proteins, warfarin, and vascular calcification. Clin J Am Soc Nephrol (2008) 1.26

Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Semin Dial (2009) 1.20

Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study. PLoS Med (2014) 1.20

Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis (2011) 1.19

Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis (2007) 1.18

Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation (2012) 1.17

Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant (2012) 1.10

A current understanding of vascular calcification in CKD. Am J Physiol Renal Physiol (2014) 1.04

Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol (2014) 1.00

Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium. Mol Pharm (2012) 0.98

Hypomagnesaemia, the kidney and the vessels. Nephrol Dial Transplant (2012) 0.97

Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy. Kidney Int (2015) 0.96

Magnesium and osteoporosis: current state of knowledge and future research directions. Nutrients (2013) 0.96

Effects of extracellular magnesium on the differentiation and function of human osteoclasts. Acta Biomater (2014) 0.94

Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6. Pflugers Arch (2013) 0.90

Impact of dialysis on gastroesophageal reflux, dyspepsia, and proton pump inhibitor treatment in patients with chronic renal failure. Eur J Gastroenterol Hepatol (2009) 0.90

Proton pump inhibitor omeprazole use is associated with low bone mineral density in maintenance haemodialysis patients. Int J Clin Pract (2009) 0.88

Proton-pump inhibitor use is associated with lower urinary magnesium excretion. Nephrology (Carlton) (2014) 0.86

Hypomagnesemia in hemodialysis patients: role of proton pump inhibitors. Am J Nephrol (2014) 0.86

Relationship between low magnesium status and TRPM6 expression in the kidney and large intestine. Am J Physiol Regul Integr Comp Physiol (2008) 0.84

Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Hemodial Int (2006) 0.83

Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis. Clin Exp Nephrol (2011) 0.80

Long-term proton pump inhibitor use is associated with vascular calcification in chronic kidney disease: a cross-sectional study using propensity score analysis. Drug Saf (2013) 0.79

The relationship between long-term proton pump inhibitor therapy and skeletal frailty. Endocrine (2015) 0.77

Effect of low-dose proton pump inhibitor on preventing upper gastrointestinal bleeding in chronic kidney disease patients receiving aspirin. J Gastroenterol Hepatol (2015) 0.77

Hypokalemic metabolic alkalosis with hypomagnesuric hypermagnesemia and severe hypocalciuria: a new syndrome? Am J Kidney Dis (1997) 0.77